Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis.
about
Treatment for inclusion body myositisIdiopathic Inflammatory Myopathies: Clinical Approach and ManagementScanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory MyopathiesMeasures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-Targeting protein homeostasis in sporadic inclusion body myositis.Immunotherapies for Immune-Mediated Myopathies: A Current PerspectiveInflammatory myopathies: clinical, diagnostic and therapeutic aspects.Treatment of sporadic inclusion body myositis with bimagrumabPharmacological methods to overcome IFN-beta antibody formation in the treatment of multiple sclerosis.A randomized, pilot trial of etanercept in dermatomyositis.Idiopathic inflammatory myopathies: a treatment update.Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational StudyKnee extensor strength exhibits potential to predict function in sporadic inclusion-body myositis.Update on treatment of inclusion body myositis.Diagnosis, pathogenesis and treatment of myositis: recent advances.Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken.Medication of inclusion body myositis: a systematic review.Long-term observational study of sporadic inclusion body myositis.Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes.Anesthetic Considerations of Sporadic Inclusion Body Myositis in an Elderly Man With Orthopedic Trauma.Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and β-amyloid in the muscle.Inflammatory Myopathies.Inclusion body myositis functional rating scale: A reliable and valid measure of disease severityInternational consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies
P2860
Q24186948-EDB32FB4-0601-416F-9BDF-F1D5B7C3007DQ26744705-F73132AE-A885-4C01-91D2-D88A69A8E1A1Q26798209-4FD89D45-586A-4BA7-8B80-403AA1DD2C01Q27021322-C89E2FF6-B3F8-4B0B-8E09-3DEC83781D6BQ27324564-D83511C8-2478-4EEA-81F3-AA8B4B272CEAQ30699742-20DBA22E-6C8B-4CD0-9279-81CA9DFD52E2Q34186450-9388643E-0507-4012-80C6-3B2D5FA4994DQ34446951-F0F85CD8-308C-426F-BA37-181D6CC420F9Q35164752-1C01EC56-8022-4760-A97B-8F32871CFB5BQ35206687-B311CE5C-14FA-4B4E-A8EB-B87F6640D118Q35580539-CDFA1931-D224-44FF-AA08-6BB28592C687Q35915998-D16E67E4-35BB-41B4-92D2-6ED7F0D48DCCQ37418497-81D805E4-68F7-4BC3-885F-06A43DD28DF1Q38093096-3D0A16F5-B3AA-4F87-BD6B-787C59DDD917Q38131849-3E430436-FF3E-47CA-8457-E336B6DC2FCCQ38244567-7F56B629-A829-4A7B-B051-1D2F61EA9E44Q38314711-5DC8D12B-FAEB-4345-B4E0-192760B3F075Q38540313-10DA3025-3181-4447-9C22-37B98B5EB1EFQ39698054-3E5AA79C-A268-4AA5-83A4-D04ABACFE0B1Q40299150-864DD396-5BE8-46EF-BF81-0E8E1CB649AFQ42079267-E4B93AE8-835F-4A58-880E-0CF534681CC9Q47195942-67E3C1F4-572E-4B5D-82FD-809E8046F1CCQ53904485-B5DBC8F5-2E39-4DA3-B27B-9ED999714148Q56049902-E4F2951E-CFA9-4740-B96E-F120B9D54F1AQ58490794-0D604CB1-869B-4E29-9E45-081C551B3EA5
P2860
Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis.
@en
Randomized pilot trial of betaINF1a
@nl
type
label
Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis.
@en
Randomized pilot trial of betaINF1a
@nl
prefLabel
Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis.
@en
Randomized pilot trial of betaINF1a
@nl
P356
P1433
P1476
Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis.
@en
P2093
Muscle Study Group
P304
P356
10.1212/WNL.57.9.1566
P407
P577
2001-11-01T00:00:00Z